Prostate Cancer
Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial.
October 5, 2023
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.
October 5, 2023
Age 70 +/- 5 Years and Cancer Specific Outcomes after Treatment of Localized Prostate Cancer: A Systematic Review.
October 5, 2023
Genomic Characterization of Locally Recurrent Prostate Cancer after Radiation Therapy.
October 4, 2023
Pilot Study of a Novel Ring Gantry-Based PET/CT Linear Accelerator in Patients with Prostate Cancer Receiving [18F]-DCFPyL for PSMA PET Imaging.
October 4, 2023
Predicting 18F-DCFPyL-PET/CT Scan Positivity in Prostate Cancer Patients with Biochemical Recurrence.
October 3, 2023
Active surveillance should be considered for select men with Grade Group 2 prostate cancer.
October 3, 2023
Biopsy and Erectile Functional Outcomes of Partial Prostate Ablation: A Systematic Review and Meta-Analysis of Prospective Studies.
October 3, 2023
Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer.
October 3, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
October 3, 2023
Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system.
October 2, 2023